Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by AscellaHealth LLC

AscellaHealth Recognized in SHSMD Calendar of Healthcare Observances for Gene Therapy and Specialty Pharmacy Awareness Month
From AscellaHealth LLC
Via Business Wire
For the Fourth Time, AscellaHealth Makes the Inc. 5000, at No. 609 in 2024, With Three-Year Revenue Growth of 746.1 Percent
From AscellaHealth LLC
Via Business Wire
AscellaHealth Releases Q2 2024 Specialty & Rare Pipeline Digest™: Increased Approvals Signal Growing Demand and Utilization of Specialty Pharmaceuticals
From AscellaHealth LLC
Via Business Wire
Philadelphia Business Journal Features AscellaHealth CFO Mario Patone in Corporate Leadership Awards
From AscellaHealth LLC
Via Business Wire
AscellaHealth Chairman and President Bill Oldham Named 2024 Philadelphia Titan 100
From AscellaHealth LLC
Via Business Wire
AscellaHealth Recognized by The Financial Times for Three Consecutive Years as One of “Americas' Fastest Growing Companies”
From AscellaHealth LLC
Via Business Wire
AscellaHealth Identifies Key Trends Worth Watching in 2024: Forecasts Robust Outlook for Specialty Pharmacy Industry
From AscellaHealth LLC
Via Business Wire
AscellaHealth and Tilde Sciences Team Up to Launch Best-in-Class Patient-Centric Program for Increased Access to Daraprim® and Enhanced Patient Outcomes
From AscellaHealth LLC
Via Business Wire
EY Announces Dea Belazi of AscellaHealth as an Entrepreneur Of The Year® 2023 National Finalist
From AscellaHealth LLC
Via Business Wire
AscellaHealth Ranked Number 231 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™
From AscellaHealth LLC
Via Business Wire
AscellaHealth Earns Merit-Based Philadelphia100 Award for Fourth Consecutive Year, Ranks #10 Among Fastest Growing, Private Companies in Philadelphia Region
From AscellaHealth LLC
Via Business Wire
AscellaHealth President and CEO Dea Belazi Delivers Impactful Discussion at 2023 SIIA Annual Meeting: Specialty Pharmaceuticals and their Impact on Self-Insured Employers
From AscellaHealth LLC
Via Business Wire
AscellaHealth Earns Number One Spot for Fastest Growing Private Company and Number Two Spot on Philadelphia Business Journal “Soaring 76” Overall List of Fastest-Growing Companies
From AscellaHealth LLC
Via Business Wire
AscellaHealth Launches Q3 2023 Specialty & Rare Pipeline Digest™: Expert Resource for FDA Approval Status of Specialty Pharmaceuticals and Cell & Gene Therapies
From AscellaHealth LLC
Via Business Wire
For the Third Time, AscellaHealth Makes the Inc. 5000 at No. 850 in 2023, With Three-Year Revenue Growth of 697.73% Percent
From AscellaHealth LLC
Via Business Wire
AscellaHealth Releases Inaugural Specialty & Rare Pipeline Digest™: Includes FDA Approval Status for Specialty Drug Product Launches and Cell & Gene Therapies
From AscellaHealth LLC
Via Business Wire
NeuroSolv Therapeutics LLC Advances Spinal Cord Injury Treatment with Development of Perineline™ and Support from AscellaHealth LLC, a Global Healthcare & Specialty Pharmacy Solutions Company
From AscellaHealth LLC
Via Business Wire
EY Announces Dea Belazi, CEO and President, AscellaHealth, as an Entrepreneur Of The Year® 2023 Greater Philadelphia Award Winner
From AscellaHealth LLC
Via Business Wire
AscellaHealth Recognized at 2023 PACT Enterprise Awards
From AscellaHealth LLC
Via Business Wire
Pharmaceutical financial solution for expensive specialty therapies wins innovation award
From AscellaHealth LLC
Via Business Wire
AscellaHealth’s PharmaFlexFund™, Pharmaceutical Financial Solution for Expensive Specialty Therapies, Shortlisted for Innovation of the Year Award
From AscellaHealth LLC
Via Business Wire
AscellaHealth Captures Two Stevie Awards, Recognized as Fastest Growing Company and Marketing Department of the Year by 2023 American Business Awards
From AscellaHealth LLC
Via Business Wire
AscellaHealth Expands Worldwide Market Position, Unifies Solutions Under One Global Brand, Brings A Rare and Special Perspective to the Industry
From AscellaHealth LLC
Via Business Wire
EY Announces Dea Belazi, CEO and President, AscellaHealth, Entrepreneur Of The Year® 2023 Greater Philadelphia Award Finalist
From AscellaHealth LLC
Via Business Wire
AscellaHealth Recognized for Two Consecutive Years as One of “Americas' Fastest Growing Companies” by The Financial Times
From AscellaHealth LLC
Via Business Wire
AscellaHealth Launches Biopharmaceutical Educational Podcast Workshop Series, Partnering with National Association of Specialty Pharmacy & Pharmacy Podcast Network
From AscellaHealth LLC
Via Business Wire
Seven Specialty Pharmacy Trends to Watch in 2023
From AscellaHealth LLC
Via Business Wire
AscellaHealth Earns Merit-Based Philadelphia100 Award for Third Consecutive Year, Ranks Among Fastest Growing, Private Companies in Philadelphia Region
From AscellaHealth LLC
Via Business Wire
AscellaHealth Earns Spot on Philadelphia Business Journal “Soaring 76” List of Fastest-Growing Companies
From AscellaHealth LLC
Via Business Wire
AscellaHealth Named National Association of Specialty Pharmacy (NASP) Strategic Channel Partner of the Year
From AscellaHealth LLC
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback